AOD-9604
Modified HGH fragment 176-191 analog targeted at fat loss without GH side effects.
Scientific Overview
AOD-9604 is the C-terminal fragment of HGH (residues 177–191) plus a tyrosine. Investigated for obesity in Phase 2 trials; TGA-listed as a complementary medicine in Australia.
Key Research Benefits
- ✓Targets stubborn fat
- ✓No effect on blood sugar
- ✓Stimulates lipolysis
Potential Side Effects
Research Protocols
Common DosagesFat Loss
“Empty stomach, ≥30 min before food”
Dose Calculator
🧮 Peptide Reconstitution Calculator
Total amount of peptide in the vial.
Volume of water used to mix.
Draw to this mark
or 0.12 mL on a U-100 syringe
Explore AOD-9604
Where to source
Vendors with public COAs that stock this category. Affiliate links are disclosed.
- Limitless Life NootropicsFL-based research-peptide supplier with Janoshik third-party COAs and a public affiliate program at ~20%.COA: JanoshikAffiliate disclosed
- SwissChems60+ peptide catalog with Janoshik COAs; weekly affiliate payouts.COA: JanoshikAffiliate disclosed
- Amino ClubEU/US-facing vendor with a 20% first-order / 10% recurring affiliate model.COA: Third-partyAffiliate disclosed
AOD-9604 by goal
Read AOD-9604's profile filtered through specific research goals.
Molecular Profile
Quick Reference
- Status
- Research Compound
- Category
- Metabolic
- Common Dosage
- 300 mcg
- Daily (AM)
Strictly for research purposes. Not for human consumption.
Related tools
Medical Disclaimer
Information provided on DoseVault is for educational and research purposes only. This website does not advocate for the human use of peptides. Peptides are currently sold as research chemicals and are not FDA-approved for human consumption. Always consult a licensed medical professional before considering any protocol.